814 research outputs found

    (E)-N′-(4-Methoxy­benzyl­idene)benzohydrazide

    Get PDF
    In the title mol­ecule, C15H14N2O2, the dihedral angle between the benzene rings is 5.93 (17)°. In the crystal, inter­molecular N—H⋯O hydrogen bonds link the mol­ecules into chains propagating in [010]

    The changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c mice

    Get PDF
    CD4+CD25+ regulatory T lymphocytes (T(R)) constitute 5–10% of peripheral CD4+ T cells in naive mice and humans, and play an important role in controlling immune responses. Accumulating evidences show that T(R )cells are involved in some physiological processes and pathologic conditions such as autoimmune diseases, transplantation tolerance and cancer, and might be a promising therapeutic target for these diseases. To evaluate the change of CD4+CD25+ T(R )cells in mouse tumor models, CD4+CD25+ subset in peripheral blood and spleen lymphocytes from normal or C26 colon-carcinoma-bearing BABL/c mice were analyzed by flow cytometry using double staining with CD4 and CD25 antibodies. The proportion of CD4+CD25+/CD4+ in spleen lymphocytes was found to be higher than that in peripheral blood lymphocytes in normal mice. No difference was observed in the proportion in peripheral blood lymphocytes between tumor bearing mice and normal mice, while there was a significant increase in the proportion in spleen lymphocytes in tumor bearing mice as compared with normal mice. Moreover, the proportion increased in accordance with the increase in the tumor sizes. The increase in the proportion was due to the decrease in CD4+ in lymphocytes, which is resulted from decreased CD4+CD25- subset in lymphocytes. Our observation suggests the CD4+CD25+/CD4+ proportion in spleen lymphocytes might be a sensitive index to evaluate the T(R )in tumor mouse models, and our results provide some information on strategies of antitumor immunotherapy targeting CD4+CD25+ regulatory T lymphocytes

    Learning against Non-credible Auctions

    Full text link
    The standard framework of online bidding algorithm design assumes that the seller commits himself to faithfully implementing the rules of the adopted auction. However, the seller may attempt to cheat in execution to increase his revenue if the auction belongs to the class of non-credible auctions. For example, in a second-price auction, the seller could create a fake bid between the highest bid and the second highest bid. This paper focuses on one such case of online bidding in repeated second-price auctions. At each time tt, the winner with bid btb_t is charged not the highest competing bid dtd_t but a manipulated price pt=α0dt+(1α0)btp_t = \alpha_0 d_t + (1-\alpha_0) b_t, where the parameter α0[0,1]\alpha_0 \in [0, 1] in essence measures the seller's credibility. Unlike classic repeated-auction settings where the bidder has access to samples (ds)s=1t1(d_s)_{s=1}^{t-1}, she can only receive mixed signals of (bs)s=1t1(b_s)_{s=1}^{t-1}, (ds)s=1t1(d_s)_{s=1}^{t-1} and α0\alpha_0 in this problem. The task for the bidder is to learn not only the bid distributions of her competitors but also the seller's credibility. We establish regret lower bounds in various information models and provide corresponding online bidding algorithms that can achieve near-optimal performance. Specifically, we consider three cases of prior information based on whether the credibility α0\alpha_0 and the distribution of the highest competing bids are known. Our goal is to characterize the landscape of online bidding in non-credible auctions and understand the impact of the seller's credibility on online bidding algorithm design under different information structures

    Initial investigation on ultrasound-guided percutaneous biopsy of lesions in the first hepatic hilum with fusion of ultrasound and multimodal imaging cognitive guidance

    Get PDF
    PurposeThis study aims to evaluate the efficacy and safety of ultrasound-guided percutaneous biopsy of the first hepatic hilum lesion, and examine its clinical value of diagnosis and treatment.MethodsWe conducted a retrospective study on patients diagnosed with the first hepatic hilum lesions at Fujian Provincial Hospital between February 2015 and October 2022. We selected patients who had lesions in the first hepatic hilum(including a 2cm surrounding area of the left/right hepatic ducts and upper-middle segment of the common bile duct) and the liver periphery(in the peripheral area of the liver, outside of the above-mentioned first hepatic porta region). These patients underwent percutaneous ultrasound-guided core needle biopsy (PUS-CNB) with cognitive fusion guidance using CT, MRI, or PET-CT. We compared the safety and efficacy of PUS-CNB in the first hepatic hilum and the liver periphery to explore the value of PUS-CNB in optimizing the clinical treatment of the first hepatic hilum lesions.ResultsThe studied includes 38 cases of the first hepatic hilum cases (18 females; 20 males), 23 presented with mass-forming tumors while the remaining 15 exhibited diffuse infiltrative tumors, with an average diameter of 4.65± 2.51 cm. The percutaneous biopsy procedure, conducted under ultrasound guidance, had an average operation time of 14.55 ± 2.73 minutes, and resulted in a postoperative bleeding volume of approximately 10.79 ± 2.79 ml. The diagnostic success rate was noted to be as high as 92.11% among the participants who underwent percutaneous biopsy of the first hepatic hilum. Procedural complications, such as bleeding, bile leakage, intestinal perforation, infection or needle tract seeding, did not occur during or after the biopsy procedure. Affected by biopsy results, 5 altered their clinical treatment plans accordingly, 24patients received non-surgical treatment, 9 underwent surgical treatment, 5 underwent radiofrequency ablation for the lesions. The study comprised a total of 112 cases for percutaneous biopsy of the liver periphery. The safety and effectiveness of the two biopsy techniques were comparable, with diagnostic success rates of 92.11% VS. 94.34%, respectively (p = 0.61).ConclusionCognitive fusion of ultrasound and multi-modal imaging for the first hepatic hilum lesion puncture biopsy is a safe and effective diagnostic procedure, with better diagnostic rate, may improve clinical value of diagnosis and treatment of various diseases
    corecore